International Clinical Trial: Examination of a supplement to manage mood and brain activity in women with premenstrual dysphoric disorder (extreme emotional, behavioral, and physical symptoms in the 1 to 2 weeks before a period)

Posted On: 2026-10-19

Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ISRCTN88979481) titled 'Examination of a supplement to manage mood and brain activity in women with premenstrual dysphoric disorder (extreme emotional, behavioral, and physical symptoms in the 1 to 2 weeks before a period)' on Oct. 19.

Study Type: Interventional

Study Design: Allocation: Randomized controlled trial Masking: Blinded (masking used) Control: Placebo Assignment: Parallel Purpose: Treatment

Primary Sponsor: Queen Mary University of London

Condition: Premenstrual dysphoric disorder (PMDD) Mental and Behavioural Disorders

Intervention: One hundred women with PMDD will be randomly allocated to one of two parallel arms. Par...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

International Clinical Trial: Examination of a supplement to manage mood and brain activity in women with premenstrual dysphoric disorder (extreme emotional, behavioral, and physical symptoms in the 1 to 2 weeks before a period)